Call us:

CANMab 440 mg Injection Biocon

CANMab 440 mg Injection Biocon

19000 INR

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Function Breast Cancer
  • Dosage 400 Mg
  • Suitable For Suitable For All
  • Storage Instructions Dry Place
  • Click to View more

Price And Quantity

  • 19000 INR
  • 5 Box

Product Specifications

  • Suitable For All
  • 400 Mg
  • Injection
  • Dry Place
  • Breast Cancer
  • Liquid

Trade Information

  • Cheque
  • 5 Box Per Day
  • 2-3 Days
  • Carton Box.
  • Australia Eastern Europe Western Europe Africa Middle East South America Asia Central America North America
  • All India

Product Description

CANMAb(TM) 440 mg Injection which contains trastuzumab used for the treatment of HER2-positive metastatic breast cancer in India. CANMAb(TM), developed jointly by Biocon Pharma and Mylan under a global partnership, is being introduced for the benefit of patients in India. Breast cancer is the most prevalent cancer among Indian women ahead of cervical cancer and CANMAb(TM) will offer a high quality, more affordable option to breast cancer patients in India. 
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Botox Injections' category

Back to top